Results 181 to 190 of about 35,770,461 (338)

A FACTOR ANALYSIS OF THE MATHEMATICAL SECTIONS OF THE SCHOLASTIC APTITUDE TEST1 [PDF]

, 1966
Robert M. Pruzek, William E. Coffman
openalex   +1 more source

Etoposide‐induced cancer cell death: roles of mitochondrial VDAC1 and calpain, and resistance mechanisms

Molecular Oncology, EarlyView.
The complex mode of action of the topoisomerase II inhibitor etoposide in triggering apoptosis involves several mechanisms: overexpression of the mitochondrial protein VDAC1, leading to its oligomerization and formation of a large channel that mediates the release of pro‐apoptotic protein; and overexpression of the apoptosis regulators p53, Bax, and ...
Aditya Karunanithi Nivedita, Varda Shoshan‐Barmatz   +1 more
wiley   +1 more source

Retraction: Risk factor analysis combined with deep learning in the risk assessment of overseas investment of enterprises. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

GENETIC ANALYSIS OF A FACTOR REGULATING MELANOGENESIS IN THE MOUSE MELANOCYTE

, 1968
Takuji Takeuchi
openalex   +2 more sources

Respiratory complex I‐mediated NAD+ regeneration regulates cancer cell proliferation through the transcriptional and translational control of p21Cip1 expression by SIRT3 and SIRT7

Molecular Oncology, EarlyView.
NAD+ regeneration by mitochondrial complex I NADH dehydrogenase is important for cancer cell proliferation. Specifically, NAD+ is necessary for the activities of NAD+‐dependent deacetylases SIRT3 and SIRT7, which suppress the expression of p21Cip1 cyclin‐dependent kinase inhibitor, an antiproliferative molecule, at the translational and transcriptional
Masato Higurashi, Kazunori Mori, Hidetsugu Nakagawa, Momoko Uchida, Fumihiro Ishikawa, Motoko Shibanuma   +5 more
wiley   +1 more source

Thermomagnetic Analysis: Experimental Factors

, 1969
P. J. Wasilewski
openalex   +2 more sources

Exploratory Factor Analysis: A Guide to Best Practice

, 2018
Marley W. Watkins
semanticscholar   +1 more source

Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial

Molecular Oncology, EarlyView.
Using mass cytometry, we analyzed serial blood samples from patients with relapsed epithelial ovarian cancer (EOC) treated with oleclumab–durvalumab combination immunotherapy in the NSGO‐OV‐UMB1/ENGOT‐OV30 trial. Our analysis identified potential predictive, monitoring, and response biomarkers detectable through liquid biopsy. These findings facilitate
Luka Tandaric, Annika Auranen, Katrin Kleinmanns, René DePont Christensen, Liv Cecilie Vestrheim Thomsen, Cara Ellen Wogsland, Emmet McCormack, Johanna Mäenpää, Kristine Madsen, Karen Stampe Petersson, Mansoor Raza Mirza, Line Bjørge   +11 more
wiley   +1 more source

Risk Factor Analysis in Vascular Access Complications for Hemodialysis Patients. [PDF]

Diagnostics (Basel)
Roşu CD, Bolintineanu SL, Căpăstraru BF, Iacob R, Stoicescu ER, Petrea CE.   +5 more
europepmc   +1 more source

Confirmatory factor analysis with ordinal data: Comparing robust maximum likelihood and diagonally weighted least squares

Behavior Research Methods, 2016
Cheng-Hsien Li
semanticscholar   +1 more source